Patent · US Active

Method for treating psoriasis by administering an antibody to interleukin-6 receptor

US8597644B2 · kind B2 · utility

16Cited by
3References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 29, 2007
Grant dateDec 3, 2013
Priority date
Expiry dateJan 10, 2029

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2039/505
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method for treating psoriasis comprising an interleukin-6 (IL-6) antagonist such as, for example, an antibody against IL-6 receptor.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.